Six Weeks of Daily Rifapentine vs. a Comparator Arm of 12-16 Week Rifamycin-based Treatment of Latent M. Tuberculosis Infection: Assessment of Safety, Tolerability and Effectiveness
Phase of Trial: Phase II/III
Latest Information Update: 09 Aug 2019
Price : $35 *
At a glance
- Drugs Rifapentine (Primary) ; Isoniazid; Rifampicin; Rifamycin
- Indications Tuberculosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms ASTERoiD
- 06 Aug 2019 Status changed from not yet recruiting to recruiting.
- 21 Jun 2019 Planned End Date changed from 1 Dec 2020 to 1 Dec 2023.
- 21 Jun 2019 Planned primary completion date changed from 1 Dec 2020 to 1 Dec 2023.